Price to Book Value Chart

View Price to Book Value for INRLF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
September 17, 2026 6.462
September 16, 2026 6.615
September 15, 2026 6.615
September 14, 2026 6.615
September 11, 2026 6.615
September 10, 2026 6.728
September 09, 2026 6.728
September 08, 2026 6.728
September 04, 2026 6.728
September 03, 2026 6.728
September 02, 2026 6.728
September 01, 2026 6.728
August 31, 2026 6.728
August 28, 2026 6.728
August 27, 2026 6.728
August 26, 2026 6.728
August 25, 2026 6.728
August 24, 2026 6.728
August 21, 2026 6.728
August 20, 2026 7.049
August 19, 2026 7.049
August 18, 2026 7.049
August 17, 2026 7.049
August 14, 2026 7.049
August 13, 2026 4.959
Date Value
August 12, 2026 4.959
August 11, 2026 4.959
August 10, 2026 4.959
August 07, 2026 4.959
August 06, 2026 4.959
August 05, 2026 4.959
August 04, 2026 4.959
August 03, 2026 4.959
July 31, 2026 4.959
July 30, 2026 4.959
July 29, 2026 5.357
July 28, 2026 5.357
July 27, 2026 5.357
July 24, 2026 5.357
July 23, 2026 5.357
July 22, 2026 5.357
July 21, 2026 5.357
July 20, 2026 5.357
July 17, 2026 5.357
July 16, 2026 5.357
July 15, 2026 5.357
July 14, 2026 5.357
July 13, 2026 5.357
July 10, 2026 5.357
July 09, 2026 5.357

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Nicox SA --
DBV Technologies SA 3.518
Cellectis SA 3.727
Genfit SA --
Innate Pharma SA --

Price to Book Value Related Metrics

PS Ratio 3.351
PEG Ratio -0.0224
Price 3.160
Earnings Yield -33.13%
Market Cap 599.30M
PEGY Ratio -0.0224